INTERNATIONAL PATENT: THERAVECTYS, INSTITUT PASTEUR FILES APPLICATION FOR "LENTIVIRAL VECTOR-BASED IMMUNOTHERAPY OF PROSTATE TUMORS"

GENEVA, April 28 -- THERAVECTYS (Bat Pasteur Biotop28 rue du Docteur Roux75015 PARIS), INSTITUT PASTEUR (25-28 rue du Docteur Roux75015 PARIS) filed a patent application (PCT/EP2025/079957) for "LENTIVIRAL VECTOR-BASED IMMUNOTHERAPY OF PROSTATE TUMORS" on Oct 16, 2025. With publication no. WO/2026/082898, the details related to the patent application was published on Apr 23, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHARNEAU, Pierre (Laboratoire Commun Pasteur-TheraVectysDepartement de Virologie - Institut Pasteur28 rue du Dr Roux75724 Paris cedex 15), MAJLESSI, Laleh (Laboratoire Comm...